Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

SUNITON TABLETS

Approval Number

SIN05937P

Drug Name

SUNITON TABLETS

Product Name

SUNITON TABLETS

Approval Date

May 21, 1991

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

M03BC51

ATC Item Name

orphenadrine, combinations

Manufacturer Information

Pharmaceutical Manufacturer

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Manufacturers

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

Ingredient Name

ORPHENADRINE CITRATE

Strength

35 mg

Drug MonographOrphenadrine

Ingredient Name

PARACETAMOL

Strength

450 mg

Drug MonographAcetaminophen

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

SUNITON TABLETS - HSA Approval | MedPath